Center for Scientific Review; Notice of Closed Meetings, 54583-54584 [2012-21753]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 172 / Wednesday, September 5, 2012 / Notices
Behavioral Genetics and Epidemiology Study
Section.
Date: October 5, 2012.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
Bethesda, MD 20892, 301–435–0694.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Academic
Research Enhancement Award (Parent R15)
AREA Review.
Date: October 5, 2012.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Date: October 5, 2012.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Dana Jeffrey Plude, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3176,
MSC 7848, Bethesda, MD 20892, 301–435–
2309, pluded@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PA11–260:
Research Project Grant (Parent R01).
Date: October 5, 2012.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Riverwalk, 420 W.
Market Street, San Antonio, TX 78205.
Contact Person: Lee S Mann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–11–
216: Early Phase Clinical Trials in Imaging
and Image-Guided Interventions.
Date: October 5, 2012.
Time: 2:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: David L Williams, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5110,
MSC 7854, Bethesda, MD 20892, (301) 435–
1174, williamsdl2@csr.nih.gov.
VerDate Mar<15>2010
19:14 Sep 04, 2012
Jkt 226001
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Shared
Instrumentation: Grant Program.
Date: October 5, 2012.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Yvonne Bennett, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301–379–3793, bennetty@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Collaborative: R01s For Clinical And Services
Studies of Mental Disorders.
Date: October 5, 2012.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Yvonne Bennett, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301–379–3793, bennetty@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 29, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–21754 Filed 9–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Motor Function, Speech and
Rehabilitation Study Section.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
54583
Date: October 1, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW.,
Washington, DC 20008.
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892, 301–402–4411, tianbi@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Aging Systems and Geriatrics Study
Section.
Date: October 8, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: James P Harwood, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5168,
MSC 7840, Bethesda, MD 20892, 301–435–
1256, harwoodj@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Virology—B Study Section.
Date: October 8–9, 2012.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: John C Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group,
Molecular and Cellular Hematology Study
Section.
Date: October 9–10, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn by Marriott—Seattle
Downtown, 800 Fairview Avenue North,
Seattle, WA 98109.
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6183,
MSC 7804, Bethesda, MD 20892, 301–495–
1213, espinozala@mail.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Macromolecular Structure
and Function D Study Section.
Date: October 9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: James W Mack, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4154,
E:\FR\FM\05SEN1.SGM
05SEN1
tkelley on DSK3SPTVN1PROD with NOTICES
54584
Federal Register / Vol. 77, No. 172 / Wednesday, September 5, 2012 / Notices
MSC 7806, Bethesda, MD 20892, (301) 435–
2037, mackj2@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences, Integrated Review Group,
Molecular and Cellular Endocrinology Study
Section.
Date: October 9, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: John Bleasdale, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170
MSC 7892, Bethesda, MD 20892, 301–435–
4514, bleasdaleje@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Auditory System
Study Section.
Date: October 9, 2012.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue NW., Washington, DC 20037.
Contact Person: Lynn E Luethke, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Pathobiology of Kidney Disease Study
Section.
Date: October 9–10, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cell Biology.
Date: October 9, 2012.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191, ipws@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Mar<15>2010
19:14 Sep 04, 2012
Jkt 226001
Dated: August 29, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–21753 Filed 9–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR–D(J2) P
Tissue Engineering Resource Center (P41).
Date: November 7–9, 2012.
Time: 6 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Best Western Hotel III Tria, 220
Alewife Brook Parkway, Cambridge, MA
02138.
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3398,
hayesj@mail.nih.gov.
Dated: August 29, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–21751 Filed 9–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Final Action Under the NIH Guidelines
for Research Involving Recombinant
DNA Molecules (NIH Guidelines)
On March 4, 2009, the
National Institutes of Health (NIH)
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Office of Biotechnology Activities,
Office of Science Policy (NIH/OBA)
published a proposal in the Federal
Register (74 FR 9411) to revise the NIH
Guidelines in two regards. The first was
to address biosafety considerations for
research with synthetic nucleic acids.
The proposal modified the scope of the
NIH Guidelines specifically to cover
certain basic and clinical research with
nucleic acid molecules created solely by
synthetic means. The second proposed
revision was to modify the criteria for
determining whether an experiment to
introduce drug resistance into a
microorganism must be reviewed by the
Recombinant DNA Advisory Committee
(RAC) and approved by the NIH Director
(as a Major Action under Section III–A–
1–a of the NIH Guidelines). Comments
submitted were discussed at the ‘‘NIH
Public Consultation on Proposed
Changes to the NIH Guidelines for
Synthetic Nucleic Acids’’ on June 23,
2009 (https://oba.od.nih.gov/rdna_rac/
rac_pub_con.html’’.
This notice sets forth final changes to
the NIH Guidelines regarding those two
proposals. The scope of the NIH
Guidelines is being modified to cover
certain classes of basic and clinical
research with synthetic nucleic acids
while exempting others. As discussed
herein, the majority of research with
synthetic nucleic acids that are not
designed to replicate does not raise
significant biosafety concerns that
warrant oversight under the NIH
Guidelines. Because of the modification
of the scope of the NIH Guidelines, the
title of the NIH Guidelines will be
revised from NIH Guidelines for
Research Involving Recombinant DNA
Molecules to NIH Guidelines for
Research Involving Recombinant or
Synthetic Nucleic Acids Molecules.
These changes also clarify the criteria
for determining whether an experiment
to introduce drug resistance into a
microorganism raises sufficient public
health issues to warrant the experiment
being reviewed by the RAC and
approved by the NIH Director under
Section III–A–1–a of the NIH
Guidelines. While the current criteria
for determining whether an experiment
requires review under Section III–A–1–
a are being retained, additional language
is being added regarding the assessment
of whether a drug is therapeutically
useful. In addition, NIH/OBA has
clarified that Institutional Biosafety
Committees (IBCs) can consult with
NIH/OBA regarding a specific
experiment that does not meet the
criteria for review under Section III–A–
1–a but nonetheless raises important
public health issues. Finally, a section
is added to give NIH/OBA the authority
E:\FR\FM\05SEN1.SGM
05SEN1
]]>Agencies
[Federal Register Volume 77, Number 172 (Wednesday, September 5, 2012)]
[Notices]
[Pages 54583-54584]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-21753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group, Motor Function, Speech and Rehabilitation
Study Section.
Date: October 1, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley
Road NW., Washington, DC 20008.
Contact Person: Biao Tian, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3166, MSC 7848, Bethesda, MD 20892, 301-402-
4411, tianbi@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Aging Systems and Geriatrics Study Section.
Date: October 8, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: James P Harwood, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD
20892, 301-435-1256, harwoodj@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group, Virology--B Study Section.
Date: October 8-9, 2012.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: John C Pugh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Vascular and Hematology Integrated Review
Group, Molecular and Cellular Hematology Study Section.
Date: October 9-10, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn by Marriott--Seattle Downtown, 800 Fairview
Avenue North, Seattle, WA 98109.
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6183, MSC 7804, Bethesda, MD 20892, 301-495-
1213, espinozala@mail.nih.gov.
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group, Macromolecular Structure and
Function D Study Section.
Date: October 9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Allerton Hotel, 701 North Michigan Avenue, Chicago,
IL 60611.
Contact Person: James W Mack, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4154,
[[Page 54584]]
MSC 7806, Bethesda, MD 20892, (301) 435-2037, mackj2@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences, Integrated Review Group, Molecular and
Cellular Endocrinology Study Section.
Date: October 9, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: John Bleasdale, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170 MSC 7892, Bethesda, MD
20892, 301-435-4514, bleasdaleje@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Auditory System Study Section.
Date: October 9, 2012.
Time: 8 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington,
DC 20037.
Contact Person: Lynn E Luethke, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166, MSC 7844, Bethesda, MD
20892, (301) 806-3323, luethkel@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Pathobiology of Kidney Disease Study
Section.
Date: October 9-10, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Atul Sahai, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-
1198, sahaia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cell Biology.
Date: October 9, 2012.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Wallace Ip, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301-435-
1191, ipws@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 29, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-21753 Filed 9-4-12; 8:45 am]
BILLING CODE 4140-01-P
